Company news
Resonance Health Ltd (ASX:RHT) news
Resonance Health Ltd news releases on 6ix. Latest, Jun 28, 2021: Appointment of Managing Director
Press releases — page 2
Appointment of Managing Director
June 27, 2021
Resignation of CEO & Management Changes
June 3, 2021
Filing of Patent Application
May 23, 2021
R&D Update - Molecular Medicine ASO Project
May 16, 2021
Appendix 4C - quarterly
April 28, 2021
Resonance Health : HepaFat-AI Receives CE Marking
February 24, 2021
HepaFat-AI receives CE Marking
February 23, 2021
HepaFat-AI Receives TGA Approval
February 18, 2021
HepaFat-AI Incorporated into Blackford Analysis
December 23, 2020
HepaFat-AI gains US FDA clearance
December 8, 2020
New Pulmonary Embolism AI Solution Developed
October 5, 2020
Execution of Licence Agreement
September 10, 2020
Resonance Health Files New Provisional Patent
May 24, 2020
Market Update
March 30, 2020
Controlled Placement Facility
March 19, 2020
Licencee & Royalty Agreement with 3DR Laboratories
February 3, 2020
Resonance Health : Partners with Siemens Healthineers
November 28, 2019
Resonance Health Partners with Siemens healthineers
November 27, 2019
New AI Tool for Automated Assessment of Liver Fat
November 21, 2019
Resonance Health Files Provisional Patent
November 20, 2019
Resonance Health contracted new clinical trials
July 19, 2019
R&D Activities Update and Appendix 3B
April 30, 2019
Response to ASX Price and Volume Query
April 15, 2019
Execution of Distribution Agreement with EnvoyAI
January 15, 2019
Execution of License Agreement
January 3, 2019
Resonance Health : Response to ASX Price and Volume Query
December 11, 2018
FDA Clearance Granted for FerriSmart
December 2, 2018
R&D Tax Incentive
November 20, 2018
Resonance Health : R&D Tax Incentive
November 19, 2018
Resonance Health : Change of Director's Interest Notice
November 15, 2018
New Work Order to provide services for Clinical Trial
October 31, 2018
Resonance Health : Pause in Trading
October 22, 2018
Resonance Health : Change of Substantial Shareholder Notification
September 6, 2018
Additional Information on Announcement Dated 23 August 2018
August 27, 2018
Resonance Health contracted for two new clinical trials
August 23, 2018
TGA, CE Mark clearance for A.I. Solution FerriSmart
July 10, 2018
Alliance Partner Agreement with Blackford Analysis
July 5, 2018
Additional Info. in relation to 4 May 2018 announcement
May 4, 2018
Resonance Deal to distribute Diabetic Retinopathy AI tool
May 3, 2018
Appointment of CEO
February 23, 2018
RHT Develops new assessment for the screening of NASH
February 20, 2018
Resonance Health contracted for new clinical trial
February 12, 2018
FerriScan contracted for two new Clinical Trials
January 12, 2018
Multi Centre testing commences for AI solution
December 15, 2017
Beta Testing Success for Cloud-Based A.I. Prototype
October 17, 2017
Beta Testing Commences for Cloud-Based A.I Prototype
August 21, 2017
Bone Marrow Iron Assessment Launch
June 22, 2017
Leading Patient NGO Endorses FerriScan and AI Technology
June 21, 2017
Artificial Intelligence Solution for Emerging Markets
June 14, 2017
Quarterly Report
April 28, 2017